Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-10-13 Sale |
2023-10-16 8:51 pm |
Bellerophon Therapeutics Inc. | BLPH | Puissance Capital Management LP Puissance Life Science Opportunities Fund VI Puissance Capital Fund (GP) LLC Wang Theodore T 10% Owner |
1,076,841 | $0.1038 | $111,776 | 0 (Direct) |
View |
| 2023-06-07 Sale |
2023-06-07 9:21 pm |
Bellerophon Therapeutics Inc. | BLPH | Puissance Life Science Opportunities Fund VI Puissance Capital Fund (GP) LLC Puissance Capital Management LP Wang Theodore T 10% Owner |
134,421 | $0.83 | $111,569 | 1,076,841 (Direct) |
View |
| 2023-05-18 Sale |
2023-05-22 6:51 pm |
Bellerophon Therapeutics Inc. | BLPH | Kim Bobae VP Reg. Affairs & Quality |
9,455 | $10 | $94,550 | 1,867 (Direct) |
View |
| 2023-05-18 Sale |
2023-05-19 8:55 pm |
Bellerophon Therapeutics Inc. | BLPH | Puissance Life Science Opportunities Fund VI Puissance Capital Fund (GP) LLC Wang Theodore T Puissance Capital Management LP 10% Owner |
560,000 | $9.46 | $5,297,600 | 1,211,262 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-07 Option Award |
2023-06-09 4:12 pm |
N/A N/A |
Bellerophon Therapeutics Inc. | BLPH | Amin Naseem Director |
47,578 | $0 | 291,865 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:12 pm |
N/A 2033-06-07 |
Bellerophon Therapeutics Inc. | BLPH | Fernandes Peter See Remarks |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:11 pm |
N/A 2033-06-07 |
Bellerophon Therapeutics Inc. | BLPH | Shah Parag Suresh VP of Business Operations |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:11 pm |
N/A 2033-06-07 |
Bellerophon Therapeutics Inc. | BLPH | Dekker Martin See Remarks |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:11 pm |
N/A 2033-06-07 |
Bellerophon Therapeutics Inc. | BLPH | Bruder Scott P Director |
14,607 | $0 | 14,607 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:10 pm |
N/A 2033-06-07 |
Bellerophon Therapeutics Inc. | BLPH | Kim Bobae VP Reg. Affairs & Quality |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:10 pm |
N/A 2033-06-07 |
Bellerophon Therapeutics Inc. | BLPH | Wang Theodore T Director |
14,607 | $0 | 14,607 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:10 pm |
N/A 2033-06-07 |
Bellerophon Therapeutics Inc. | BLPH | Cloyd Mary Ann Director |
14,607 | $0 | 14,607 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:10 pm |
N/A 2033-06-07 |
Bellerophon Therapeutics Inc. | BLPH | Teufel Crispin Director |
14,607 | $0 | 14,607 (Direct) |
View |
| 2023-05-18 Exercise |
2023-05-22 6:51 pm |
N/A N/A |
Bellerophon Therapeutics Inc. | BLPH | Kim Bobae VP Reg. Affairs & Quality |
1,022 | $7.5 | 1,867 (Direct) |
View |
| 2023-05-18 Exercise |
2023-05-22 6:51 pm |
N/A 2026-12-07 |
Bellerophon Therapeutics Inc. | BLPH | Kim Bobae VP Reg. Affairs & Quality |
1,288 | $0 | 1,867 (Direct) |
View |
| 2023-05-18 Exercise |
2023-05-22 6:51 pm |
N/A N/A |
Bellerophon Therapeutics Inc. | BLPH | Kim Bobae VP Reg. Affairs & Quality |
266 | $7.35 | 1,867 (Direct) |
View |
Ownership |
2023-04-03 5:46 pm |
N/A N/A |
Bellerophon Therapeutics Inc. | BLPH | Kim Bobae VP Reg. Affairs & Quality |
0 | $0 | 74,655 (Direct) |
View |
| 2023-02-10 Option Award |
2023-02-14 7:32 pm |
N/A N/A |
Bellerophon Therapeutics Inc. | BLPH | Amin Naseem Director |
84,000 | $0 | 244,287 (Direct) |
View |
| 2023-02-10 Option Award |
2023-02-14 4:48 pm |
2024-02-10 2033-02-10 |
Bellerophon Therapeutics Inc. | BLPH | Teufel Crispin Director |
29,000 | $1.52 | 29,000 (Direct) |
View |
| 2023-02-10 Option Award |
2023-02-14 4:47 pm |
N/A 2033-02-10 |
Bellerophon Therapeutics Inc. | BLPH | Dekker Martin VP OF ENGINEERING & MANUFACTUR |
50,000 | $1.52 | 50,000 (Direct) |
View |
| 2023-02-10 Option Award |
2023-02-14 4:47 pm |
N/A 2033-02-10 |
Bellerophon Therapeutics Inc. | BLPH | Shah Parag Suresh VP OF BUSINESS OPERATIONS |
50,000 | $1.52 | 50,000 (Direct) |
View |
| 2023-02-10 Option Award |
2023-02-14 4:46 pm |
N/A 2033-02-10 |
Bellerophon Therapeutics Inc. | BLPH | Fernandes Peter CHIEF EXECUTIVE OFFICER |
100,000 | $1.52 | 100,000 (Direct) |
View |
| 2023-02-10 Option Award |
2023-02-14 4:46 pm |
N/A 2033-02-10 |
Bellerophon Therapeutics Inc. | BLPH | Laccona Nicholas FINANCIAL OFFICER, (PFO & PAO) |
50,000 | $1.52 | 50,000 (Direct) |
View |
| 2023-02-10 Option Award |
2023-02-14 4:45 pm |
2024-02-10 2033-02-10 |
Bellerophon Therapeutics Inc. | BLPH | Wang Theodore T Director 10% Owner |
29,000 | $1.52 | 29,000 (Direct) |
View |
| 2023-02-10 Option Award |
2023-02-14 4:45 pm |
2024-02-10 2033-02-10 |
Bellerophon Therapeutics Inc. | BLPH | Cloyd Mary Ann Director |
29,000 | $1.52 | 29,000 (Direct) |
View |
| 2023-02-10 Option Award |
2023-02-14 4:45 pm |
2024-02-10 2033-02-10 |
Bellerophon Therapeutics Inc. | BLPH | Bruder Scott P Director |
29,000 | $1.52 | 29,000 (Direct) |
View |
| 2022-12-09 Tax Withholding |
2022-12-13 5:26 pm |
N/A N/A |
Bellerophon Therapeutics Inc. | BLPH | Dekker Martin VP OF ENGINEERING & MANUFACTUR |
7,834 | $0.9301 | 43,166 (Direct) |
View |
| 2022-12-09 Exercise |
2022-12-13 5:26 pm |
N/A N/A |
Bellerophon Therapeutics Inc. | BLPH | Dekker Martin VP OF ENGINEERING & MANUFACTUR |
25,500 | $0 | 43,166 (Direct) |
View |
| 2022-12-09 Tax Withholding |
2022-12-13 5:25 pm |
N/A N/A |
Bellerophon Therapeutics Inc. | BLPH | Shah Parag Suresh VP OF BUSINESS OPERATIONS |
7,834 | $0.9301 | 43,166 (Direct) |
View |
| 2022-12-09 Exercise |
2022-12-13 5:25 pm |
N/A N/A |
Bellerophon Therapeutics Inc. | BLPH | Shah Parag Suresh VP OF BUSINESS OPERATIONS |
25,500 | $0 | 43,166 (Direct) |
View |
| 2022-12-09 Tax Withholding |
2022-12-13 5:25 pm |
N/A N/A |
Bellerophon Therapeutics Inc. | BLPH | Laccona Nicholas FINANCIAL OFFICER, (PFO & PAO) |
5,530 | $0.9301 | 30,470 (Direct) |
View |
| 2022-12-09 Exercise |
2022-12-13 5:25 pm |
N/A N/A |
Bellerophon Therapeutics Inc. | BLPH | Laccona Nicholas FINANCIAL OFFICER, (PFO & PAO) |
18,000 | $0 | 30,470 (Direct) |
View |
| 2022-12-09 Tax Withholding |
2022-12-13 5:25 pm |
N/A N/A |
Bellerophon Therapeutics Inc. | BLPH | Fernandes Peter PRINCIPAL EXECUTIVE OFFICER |
9,985 | $0.9301 | 55,015 (Direct) |
View |
| 2022-12-09 Exercise |
2022-12-13 5:25 pm |
N/A N/A |
Bellerophon Therapeutics Inc. | BLPH | Fernandes Peter PRINCIPAL EXECUTIVE OFFICER |
32,500 | $0 | 55,015 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 4:31 pm |
N/A N/A |
Bellerophon Therapeutics Inc. | BLPH | Fernandes Peter CHIEF REGULATORY & SAFETY OFFR |
65,000 | $0 | 65,000 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 4:31 pm |
N/A N/A |
Bellerophon Therapeutics Inc. | BLPH | Dekker Martin VP OF ENGINEERING & MANUFACTUR |
51,000 | $0 | 51,000 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 4:30 pm |
N/A N/A |
Bellerophon Therapeutics Inc. | BLPH | Shah Parag Suresh VP OF BUSINESS OPERATIONS |
51,000 | $0 | 51,000 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 4:30 pm |
N/A N/A |
Bellerophon Therapeutics Inc. | BLPH | Laccona Nicholas FINANCIAL OFFICER, (PFO & PAO) |
36,000 | $0 | 36,000 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 4:10 pm |
2022-12-31 2031-12-31 |
Bellerophon Therapeutics Inc. | BLPH | Cloyd Mary Ann Director |
21,828 | $3.1 | 36,300 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 4:10 pm |
2022-12-31 2031-12-31 |
Bellerophon Therapeutics Inc. | BLPH | Wang Theodore T Director 10% Owner |
21,828 | $3.1 | 35,634 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 4:10 pm |
2022-12-31 2031-12-31 |
Bellerophon Therapeutics Inc. | BLPH | Teufel Crispin Director |
21,828 | $3.1 | 33,087 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 4:10 pm |
2022-12-31 2031-12-31 |
Bellerophon Therapeutics Inc. | BLPH | Bruder Scott P Director |
21,828 | $3.1 | 36,966 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 4:10 pm |
2022-12-31 2031-12-31 |
Bellerophon Therapeutics Inc. | BLPH | Amin Naseem Director |
8,671 | $3.1 | 184,096 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 4:10 pm |
N/A N/A |
Bellerophon Therapeutics Inc. | BLPH | Amin Naseem Director |
39,032 | $0 | 184,096 (Direct) |
View |
Ownership |
2021-10-08 5:26 pm |
N/A 2030-09-10 |
Bellerophon Therapeutics Inc. | BLPH | Laccona Nicholas Controller, (PFO & PAO) |
0 | $0 | 1,500 (Direct) |
View |
| 2021-06-07 Option Award |
2021-06-08 12:37 pm |
N/A N/A |
Bellerophon Therapeutics Inc. | BLPH | Puissance Life Science Opportunities Fund VI Puissance Capital Fund (GP) LLC Puissance Capital Management LP Puissance Capital Management (GP) LLC Wang Theodore T 10% Owner |
8,189 | $4 | 1,771,262 (Direct) |
View |
| 2021-04-26 Option Award |
2021-04-26 12:39 pm |
2016-11-29 2023-11-29 |
Bellerophon Therapeutics Inc. | BLPH | Puissance Life Science Opportunities Fund VI Puissance Capital Fund (GP) LLC Puissance Capital Management LP Puissance Capital Management (GP) LLC Wang Theodore T 10% Owner |
685,236 | $0 | 2,829,263 (Direct) |
View |
| 2021-04-26 Option Award |
2021-04-26 12:39 pm |
N/A N/A |
Bellerophon Therapeutics Inc. | BLPH | Puissance Life Science Opportunities Fund VI Puissance Capital Fund (GP) LLC Puissance Capital Management LP Puissance Capital Management (GP) LLC Wang Theodore T 10% Owner |
609,231 | $4 | 2,829,263 (Direct) |
View |
| 2021-03-31 Option Award |
2021-04-02 4:10 pm |
N/A N/A |
Bellerophon Therapeutics Inc. | BLPH | Peacock Jonathan M Director |
15,308 | $0 | 157,033 (Direct) |
View |